Medicines for the Treatment of Gastrointestinal Diseases and Metabolic Disorders

The Communal Non-Profit Enterprise "Prykarpattia Clinical Oncology Center of the Ivano-Frankivsk Regional Council" is conducting a procurement for essential medicines. The tender covers a range of pharmaceutical products, including Meropenem (powder for injection/infusion, 1g), Letrozole tablets (2.5mg), Abiraterone tablets (500mg), Caspofungin (powder for concentrate for solution for infusion, 50mg vial), and Ondansetron injection solution (2mg/ml, 4ml). These medications are intended for the treatment of gastrointestinal diseases, metabolic disorders, and are also categorized under general anti-infective agents, vaccines, antineoplastic agents, and immunomodulators, as well as antiviral agents. The specific CPV codes involved are 33650000-1 and 33651400-2. This procurement is vital for the oncology center to ensure the availability of critical treatments for its patients, particularly those undergoing cancer therapy or suffering from related complications. The tender aims to secure a reliable supply of high-quality pharmaceuticals to support the center's medical services and treatment protocols.

This is a supplies contract in the health and medical services sector, with a focus on Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 3.4 million.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.